View Post

Naloxone Updates

Update: FDA now recommends prescribing naloxone and requires new labeling changes for opioids In its Drug Safety Communication from July 23, 2020, the Food and Drug Administration (FDA) has announced that it recommends that health care professionals consider prescribing naloxone to patients at increased risk of opioid overdose, including those taking benzodiazepines or other CNS depressants, regardless of whether the …